Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 août 2010 08h00 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Settles All Securities Class Actions

PHILADELPHIA, Aug. 24, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that, as result of court mediation proceedings, it has entered into a written agreement in...
18 août 2010 08h00 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Awarded $188 Million Judgment Against JCI

PHILADELPHIA, Aug. 18, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that its six-year litigation battle with the South African investment conglomerate JCI Ltd.,...
06 août 2010 15h16 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. 2nd Quarter 2010 Financial Results

PHILADELPHIA, Aug. 6, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash...
19 juil. 2010 08h00 HE | Source: Hemispherx Biopharma, Inc.

The Indian Drugs Controller General Approves Start of Clinical Study of Hemispherx Biopharma's Natural Interferon Product, Alferon N Injection(R), in Hospitalized Flu Patients

PHILADELPHIA, July 19, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB), an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for...
15 juil. 2010 08h00 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Publishes Full Report of Three Year Joint Research Program at Japanese NIID

PHILADELPHIA, July 15, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") announced that it was publicizing the full technical (unedited) report in Japanese, prepared...
12 juil. 2010 08h00 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Reports Successful Culmination of Three Year Joint Research Program at Japanese NIID

PHILADELPHIA, July 12, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director,...
15 juin 2010 13h00 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Licenses Platform Technologies to GP Pharm

PHILADELPHIA, June 15, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx"), announced that the Company executed an exclusive revenue sharing Sales,...
17 mai 2010 06h00 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Prepares Application to Initiate Phase II Clinical Trials in China With Ampligen(R)

PHILADELPHIA, May 17, 2010 (GLOBE NEWSWIRE) -- As part of its expanding international program Hemispherx Biopharma, Inc. (NYSE Amex:HEB), (the "Company"), announced an agreement with Fountain Medical...
13 mai 2010 08h00 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present at the Rodman Healthcare Conference

PHILADELPHIA, May 13, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), today announced that the Company will participate in the Rodman & Renshaw 6th Annual...
07 mai 2010 16h17 HE | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. 1st Quarter 2010 Financial Results

PHILADELPHIA, May 7, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended March 31, 2010. The net loss (including non-cash...

Page précédente